N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
TG Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 19
- TOTAL
RATINGS
MyoKardia vs TG Therapeutics
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
TG Therapeutics
TG Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of TG Therapeutics. Their current market cap is $6.88B.
4/5
Product Quality
3/5
4/5
Pricing
3/5
4/5
Customer Service
3.1/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 33
-33
NPS Score
| 25% | Promoters |
|---|---|
| 17% | Passive |
| 58% | Detractors |
See how MyoKardia compares to its competitors
Working at MyoKardia vs Working at TG Therapeutics
Not enough ratings
CEO Rating
75 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
TG Therapeutics
Employees at TG Therapeutics rate their CEO, Michael S. Weiss, 75/100.